Comparative analysis of assays for detection of cell-mediated immunity toward cytomegalovirus and M. tuberculosis in samples from deceased organ donors

American Journal of Transplantation

Volumn 14, Issue 9, 2014, Pages 2159-2167

  Schmidt, T ^a   Schub, D ^a   Wolf, M ^a   Dirks, J ^a   Ritter, M ^a   Leyking, S ^a   Singh, M ^b   Zawada, A M ^a   Blaes Eise, A B ^c   Samuel, U ^c   Sester, U ^a   Sester, M ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b LIONEX DIAGNOSTICS AND THERAPEUTICS GMBH   (Germany)

^c Deutsche Stiftung Organtransplantation   (Germany)

Author keywords

Clinical research practice; donors and donation: donor derived infections; immunobiology; infection; infection and infectious agents; infectious disease; monitoring: immune; mycobacterial; organ transplantation in general; risk assessment risk stratification; translational research science; viral: Cytomegalovirus (CMV)

Indexed keywords

CULTURE FILTRATE PROTEIN 10; CYTOMEGALOVIRUS ANTIBODY; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; IMMUNOGLOBULIN G; MYCOBACTERIUM ANTIGEN;

ADAPTIVE IMMUNITY; ADULT; ANTIGEN DETECTION; ARTICLE; BRAIN DEATH; CADAVER DONOR; CAUSE OF DEATH; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOMEGALOVIRUS INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GERMANY; HUMAN; INTERFERON GAMMA RELEASE ASSAY; LEUKOCYTE COUNT; LIVING DONOR; MALE; ORGAN DONOR; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; TUBERCULIN TEST; TUBERCULOSIS; AGED; CADAVER; CYTOMEGALOVIRUS; DONOR; IMMUNOLOGY; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS;

ADULT; AGED; CADAVER; CYTOMEGALOVIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNITY, CELLULAR; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; TISSUE DONORS;

EID: 84906219343     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12787     Document Type: Article

References (40)

1. Morris MI, Daly JS, Blumberg E, et al. Diagnosis and management of tuberculosis in transplant donors: A donor-derived infections consensus conference report. Am J Transplant 2012; 12: 2288-2300.
2. Fishman JA, Issa NC., Infection in organ transplantation: Risk factors and evolving patterns of infection. Infect Dis Clin North Am 2010; 24: 273-283.
3. Chong PP, Razonable RR., Diagnostic and management strategies for donor-derived infections. Infect Dis Clin North Am 2013; 27: 253-270.
4. Bumbacea D, Arend SM, Eyuboglu F, et al. The risk of tuberculosis in transplant candidates and recipients: A TBNET consensus statement. Eur Respir J 2012; 40: 990-1013.
5. Mack U, Migliori GB, Sester M, et al. LTBI: Latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J 2009; 33: 956-973.
6. Sester M, Gärtner BC, Sester U, Girndt M, Mueller-Lantzsch N, Köhler H., Is the CMV serologic status always accurate?-A comparative analysis of humoral and cellular immunity. Transplantation 2003; 76: 1229-1231.
7. Ritter M, Schmidt T, Dirks J, et al. Cytomegalovirus-specific T cells are detectable in early childhood and allow assignment of the infection status in children with passive maternal antibodies. Eur J Immunol 2013; 43: 1099-1108.
8. Sester U, Presser D, Dirks J, Gärtner BC, Köhler H, Sester M., PD-1 expression and IL-2 loss of cytomegalovirus-specific T cells correlates with viremia and reversible functional anergy. Am J Transplant 2008; 8: 1486-1497.
9. Sester M, Sester U, Clauer P, et al. Tuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in hemodialysis patients. Kidney Int 2004; 65: 1826-1834.
10. Sester U, Wilkens H, van Bentum K, et al. Impaired detection of Mycobacterium tuberculosis immunity in patients using high levels of immunosuppressive drugs. Eur Respir J 2009; 34: 702-710.
11. Sester M, Sester U, Gärtner B, et al. Levels of virus-specific CD4 T cells correlate with cytomegalovirus control and predict virus-induced disease after renal transplantation. Transplantation 2001; 71: 1287-1294.
12. Landis JR, Koch GG., The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174.
13. Schmidt T, Ritter M, Dirks J, Gartner BC, Sester U, Sester M., Cytomegalovirus-specific T-cell immunity to assign the infection status in individuals with passive immunity: A proof of principle. J Clin Virol 2012; 54: 272-275.
14. Lubeck PR, Doerr HW, Rabenau HF., Epidemiology of human cytomegalovirus (HCMV) in an urban region of Germany: What has changed ? Med Microbiol Immunol 2010; 199: 53-60.
15. Enders G, Daiminger A, Lindemann L, et al. Cytomegalovirus (CMV) seroprevalence in pregnant women, bone marrow donors and adolescents in Germany, 1996-2010. Med Microbiol Immunol 2012; 201: 303-309.
16. Walker S, Fazou C, Crough T, et al. Ex vivo monitoring of human cytomegalovirus-specific CD8+ T-cell responses using QuantiFERON-CMV. Transpl Infect Dis 2007; 9: 165-170.
17. Giulieri S, Manuel O., QuantiFERON(R)-CMV assay for the assessment of cytomegalovirus cell-mediated immunity. Expert Rev Mol Diagn 2011; 11: 17-25.
18. Cantisan S, Lara R, Montejo M, et al. Pretransplant interferon-gamma secretion by CMV-specific CD8+ T cells informs the risk of CMV replication after transplantation. Am J Transplant 2013; 13: 738-745.
19. Boddie DE, Currie DG, Eremin O, Heys SD., Immune suppression and isolated severe head injury: A significant clinical problem. Br J Neurosurg 2003; 17: 405-417.
20. Meert KL, Long M, Kaplan J, Sarnaik AP., Alterations in immune function following head injury in children. Crit Care Med 1995; 23: 822-828.
21. Rothel JS, Jones SL, Corner LA, Cox JC, Wood PR., The gamma-interferon assay for diagnosis of bovine tuberculosis in cattle: Conditions affecting the production of gamma-interferon in whole blood culture. Aust Vet J 1992; 69: 1-4.
22. Oxford Immunotec, T-cell Xtend package insert. PI-TT.610-UK-V5. Available at: http://oxfordimmunotec.com/international/wp-content/uploads/sites/3/PI-TT. 610-UK-v58ba0.pdf. Accessed March 3, 2014.
23. Van Laethem F, Baus E, Smyth LA, et al. Glucocorticoids attenuate T cell receptor signaling. J Exp Med 2001; 193: 803-814.
24. Widmann T, Sester U, Gartner BC, et al. Levels of CMV specific CD4 T cells are dynamic and correlate with CMV viremia after allogeneic stem cell transplantation. PLoS ONE 2008; 3: e3634.
25. Sanders VM, Straub RH., Norepinephrine, the beta-adrenergic receptor, and immunity. Brain Behav Immun 2002; 16: 290-332.
26. Kalinichenko VV, Mokyr MB, Graf LH Jr., Cohen RL, Chambers DA., Norepinephrine-mediated inhibition of antitumor cytotoxic T lymphocyte generation involves a beta-adrenergic receptor mechanism and decreased TNF-alpha gene expression. J Immunol 1999; 163: 2492-2499.
27. Torres KC, Antonelli LR, Souza AL, Teixeira MM, Dutra WO, Gollob KJ., Norepinephrine, dopamine and dexamethasone modulate discrete leukocyte subpopulations and cytokine profiles from human PBMC. J Neuroimmunol 2005; 166: 144-157.
28. Doberne D, Gaur RL, Banaei N., Preanalytical delay reduces sensitivity of QuantiFERON-TB gold in-tube assay for detection of latent tuberculosis infection. J Clin Microbiol 2011; 49: 3061-3064.
29. Shanaube K, De Haas P, Schaap A, et al. Intra-assay reliability and robustness of QuantiFERON(R)-TB Gold In-Tube test in Zambia. Int J Tuberc Lung Dis 2010; 14: 828-833.
30. Herrera V, Perry S, Parsonnet J, Banaei N., Clinical application and limitations of interferon-gamma release assays for the diagnosis of latent tuberculosis infection. Clin Infect Dis 2011; 52: 1031-1037.
31. Herrera V, Yeh E, Murphy K, Parsonnet J, Banaei N., Immediate incubation reduces indeterminate results for QuantiFERON-TB Gold in-tube assay. J Clin Microbiol 2010; 48: 2672-2676.
32. Mancuso JD, Mazurek GH, Tribble D, et al. Discordance among commercially available diagnostics for latent tuberculosis infection. Am J Respir Crit Care Med 2012; 185: 427-434.
33. Zwerling A, Benedetti A, Cojocariu M, et al. Repeat IGRA testing in Canadian health workers: Conversions or unexplained variability ? PLoS ONE 2013; 8: e54748.
34. Dorman SE, Belknap R, Graviss EA, et al. Interferon-gamma release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States. Am J Respir Crit Care Med 2014; 189: 77-87.
35. Zwerling A, Behr MA, Verma A, Brewer TF, Menzies D, Pai M., The BCG World Atlas: A database of global BCG vaccination policies and practices. PLoS Med 2011; 8: e1001012.
36. Hinks TS, Varsani N, Godsiff DT, et al. High background rates of positive tuberculosis-specific interferon-gamma release assays in a low prevalence region of UK: A surveillance study. BMC Infect Dis 2012; 12: 339.
37. Sester M, Sotgiu G, Lange C, et al. Interferon-gamma release assays for the diagnosis of active tuberculosis: A systematic review and meta-analysis. Eur Respir J 2011; 37: 100-111.
38. Mortensen E, Hellinger W, Keller C, et al. Three cases of donor-derived pulmonary tuberculosis in lung transplant recipients and review of 12 previously reported cases: Opportunities for early diagnosis and prevention. Transpl Infect Dis 2014; 16: 67-75.
39. Kotton CN, Hibberd PL., Travel medicine and transplant tourism in solid organ transplantation. Am J Transplant 2013; 13 (Suppl 4): 337-347.
40. Pai M, Zwerling A, Menzies D., Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: An update. Ann Intern Med 2008; 149: 177-184.